BOSTON, March 30, 2026 -- Aktis Oncology, Inc. (NASDAQ:AKTS) (the “Company”), a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large populations, including those not...
Jeff Collins will participate in the US-India BioPharma Summit (theme: "Delivering Affordable Innovation through Cross-Border Partnerships") in Cambridge, MA
News | 06. 13. 2008
